VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
28 hedge funds and large institutions have $369M invested in VectivBio Holding AG Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 0 closing their positions.
120% more capital invested
Capital invested by funds: $168M → $369M (+$201M)
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
33% more funds holding
Funds holding: 21 → 28 (+7)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$18.8M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$18.8M |
| 3 |
VA
VR Adviser
New York
|
+$15M |
| 4 |
CA
CHI Advisors
New York
|
+$11.1M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$155K |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$151K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$50.6K |
| 4 |
Jane Street
New York
|
-$37.6K |
| 5 |
Citigroup
New York
|
-$2.42K |
VECT Hedge Fund Activity: Q4 2022 in Review
28 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q4 2022, worth a combined $369M — up 120% from $168M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VECT positions and 0 closed out — a net gain of 7 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was TCG Crossover Management, opening a new position worth an estimated $18.8M. The largest seller was Balyasny Asset Management, cutting an estimated $155K.
- 28 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q4 2022, up from 21 in Q3 2022.
- Funds reported $369M of VectivBio Holding AG Ordinary Shares stock for Q4 2022, up 120% quarter-over-quarter.
- 7 funds opened new VectivBio Holding AG Ordinary Shares positions in Q4 2022 and 0 closed out, a net change of +7 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q4 2022 was TCG Crossover Management, an estimated $18.8M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q4 2022 was Balyasny Asset Management, an estimated $155K sold.
Based on aggregated 13F filings for Q4 2022.